Gregory Fiore - 01 Aug 2022 Form 4 Insider Report for Brooklyn ImmunoTherapeutics, Inc. (ERNA)

Role
Director
Signature
/s/ Gregory Fiore
Issuer symbol
ERNA
Transactions as of
01 Aug 2022
Net transactions value
$0
Form type
4
Filing time
03 Aug 2022, 20:01:27 UTC
Previous filing
07 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ERNA Stock Option (right to buy) Award $0 +95,100 $0.000000 95,100 01 Aug 2022 Common Stock, par value $0.005 per share 95,100 $0.4900 Direct F1
transaction ERNA Stock Option (right to buy) Award $0 +165,800 $0.000000 165,800 01 Aug 2022 Common Stock, par value $0.005 per share 165,800 $0.4900 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable over one year (subject to continued service), with 25% of the shares vesting every three months from the grant date.
F2 The stock option vests and becomes exercisable over two years (subject to continued service), with 1/3 of the shares vesting on the grant date and the remaining shares vesting in 24 substantially equal monthly installments thereafter.